Annals of Surgical Oncology

, Volume 17, Issue 1, pp 338–339 | Cite as

The Era of Robotic Surgery for Colorectal Cancer

Gastrointestinal Oncology


Rectal Cancer Anastomotic Leak Total Mesorectal Excision Robotic Surgery Distal Resection Margin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Luca F, Cenciarelli S, Valvo M, Pozzi S, Faso FL, Ravizza D, et al. Full robotic left colon and rectal cancer resection: technique and early outcome. Ann Surg Oncol. 2009;16(5):1274–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Ziogas D, Roukos D. Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc. 2008;22(5):1405–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149–54.CrossRefPubMedGoogle Scholar
  4. 4.
    Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J. Long-term outcome of laparoscopic surgery for colorectal cancer: a Cochrane systematic review of randomised controlled trials. Cancer Treat Rev. 2008;34(6):498–504.CrossRefPubMedGoogle Scholar
  5. 5.
    Roukos DH. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol. 2009;27(8):1337–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97.CrossRefPubMedGoogle Scholar
  7. 7.
    Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1.CrossRefPubMedGoogle Scholar
  8. 8.
    Ziogas D, Roukos DH. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol. 2009;16(7):1771–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Roukos DH, Ziogas D. Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian knot”? Ann Surg Oncol. 2009;16(3):774–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Liakakos T, Roukos DH. More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene–environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9(1):1–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358(15):1636.PubMedGoogle Scholar
  14. 14.
    Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41.CrossRefPubMedGoogle Scholar
  15. 15.
    Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol. 2009;16(3):772–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Roukos DH. Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg. 2009;249(6):1067–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Roukos DH. Radiation therapy for breast cancer. N Engl J Med. 2009;360(13):1362; author reply 1363.CrossRefPubMedGoogle Scholar
  18. 18.
    Roukos DH. Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn. 2009;9(3):227–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Roukos DH. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn. 2009;9(3):217–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Roukos DH. Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther. 2009;9(4):389–92.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Ioannina, School of MedicineIoanninaGreece

Personalised recommendations